Lupeol Alleviates Myocardial Ischemia-Reperfusion Injury in Rats by Regulating NF-[Formula: see text]B and Nrf2

Jing Li1, Xuming Ma1, Jun Yang1

  • 1Department of Cardiology, Gansu Provincial Hospital, Gansu, Lanzhou 730000, P. R. China.

Insights

Lupeol, a compound from Chinese herbs, significantly reduces heart damage from ischemia-reperfusion injury (MIRI) in rats. It works by decreasing inflammation, apoptosis, and oxidative stress via NF-κB and Nrf2 pathways.

Area of Science:

  • Cardiology
  • Pharmacology
  • Biochemistry

Background:

  • Cardiovascular diseases, including myocardial infarction and ischemia-reperfusion (I/R) injury, pose a significant global health challenge.
  • Understanding the complex mechanisms of myocardial I/R injury (MIRI) is crucial for clinical advancements.
  • Lupeol, a bioactive compound found in medicinal herbs, has demonstrated various bioactivities, but its role in MIRI remains largely unexplored.

Purpose of the Study:

  • To investigate the cardioprotective effects of lupeol against myocardial ischemia-reperfusion injury (MIRI) in a rat model.
  • To elucidate the underlying mechanisms, including anti-inflammatory, anti-apoptotic, and anti-oxidative properties of lupeol in MIRI.
  • To explore the potential involvement of NF-κB and Nrf2 signaling pathways in lupeol's protective effects.

Main Methods:

  • Establishment of a rat myocardial I/R model.
  • Assessment of myocardial infarction size using 2,3,5-triphenyltetrazolium chloride (TTC) staining.
  • Quantification of inflammatory cytokines (IL-10, IL-1β, TNF-α, IL-6), CK-MB, and LDH levels via qRT-PCR and ELISA.
  • Evaluation of cellular apoptosis using TUNEL staining.
  • Analysis of NF-κB and Nrf2 signaling pathway modulation.

Main Results:

  • Lupeol administration significantly reduced myocardial infarct size following I/R.
  • Lupeol treatment ameliorated I/R-induced myocardial inflammation, apoptosis, and oxidative stress.
  • The cardioprotective effects of lupeol were associated with the modulation of NF-κB and Nrf2 signaling pathways.

Conclusions:

  • Lupeol exhibits significant cardioprotective effects against myocardial ischemia-reperfusion injury in a rat model.
  • These protective effects are attributed to lupeol's anti-oxidant, anti-inflammatory, and anti-apoptotic activities.
  • Lupeol's therapeutic potential in mitigating MIRI is linked to its modulation of NF-κB and Nrf2 signaling pathways, suggesting it as a promising therapeutic agent.

Related Concept Videos